Sprites
Mein FinanzNachrichtenJetzt AnmeldenPasswort vergessen?
Montag, 28.05.2012Börsentäglich über 11.000 News von 416 internationalen Medien
Erweiterte
Suche
Ad hoc-Mitteilungen

BIOPHARM ASIA INC

WKN: A1CU18  ISIN: US09071E1047  Ticker-Symbol: BYP 
Aktie:
Branche
Pharma
Aktienmarkt
ASIEN
1-Jahres-Chart
BIOPHARM ASIA INC Chart 1 Jahr
1-Woche-Intraday-Chart
BIOPHARM ASIA INC 1-Woche-Intraday-Chart

Aktuelle News zur BIOPHARM ASIA Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache:
LeserMedien
06.04. 9
03.04. 19
NEW YORK, NY and TONGHUA, CHINA -- (Marketwire) -- 04/03/12 -- Biopharm Asia, Inc. (PINKSHEETS: BFAR) announced a status update regarding restated financial results of 2008, 2009 and 2010. As the...
Mehr lesen zu:
Biopharm Asia Announces Status of Restatement of Financial Reports and Its Intention to File Form 10 to Commence Filing SEC Reports
26.01. 59
NEW YORK, NY and TONGHUA, CHINA -- (Marketwire) -- 01/26/12 -- BioPharm Asia, Inc. (PINKSHEETS: BFAR) (the "Company") announced today that the company entered into an agreement to acquire Xiamen Tongji...
Mehr lesen zu:
BioPharm Asia Acquires Specialty Hospital in Fujian
19.12. 46
NEW YORK, NY and TONGHUA, CHINA -- (Marketwire) -- 12/19/11 -- BioPharm Asia (PINKSHEETS: BFAR) and Elite Capital Group announced today the signing of a consulting agreement for the development of...
Mehr lesen zu:
BioPharm Asia Announces Hospital Management Contract / BioPharm Asia Is Engaged as Master Consultant for New Hospital in BEIJING
08.12. 44
NEW YORK, NY and TONGHUA, CHINA -- (Marketwire) -- 12/08/11 -- BioPharm Asia, Inc. (PINKSHEETS: BFAR), a producer, distributor and retailer of medical products in China, today announced appointment...
Mehr lesen zu:
BioPharm Asia Appoints Independent Director
05.12. 67
NEW YORK, NY and TONGHUA, CHINA -- (Marketwire) -- 12/05/11 -- BioPharm Asia, Inc. (OTCBB: BFAR), a producer, distributor and retailer of medical products in China, today announced its financial results...
Mehr lesen zu:
BioPharm Asia Announces Preliminary Unaudited Third Quarter 2011 Results / Revenue Increases 5.6% to $47.2 Million; Net Income Up 6% to $6.9 Million
6 Nachrichten in den letzten 6 Monaten